198 related articles for article (PubMed ID: 32726398)
1. Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation.
Zou J; Ciurea SO; Kongtim P; Yi M; Carmazzi Y; Rondon G; Srour S; Partlow D; Champlin RE; Cao K
Blood Adv; 2020 Aug; 4(15):3474-3485. PubMed ID: 32726398
[TBL] [Abstract][Full Text] [Related]
2. Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study.
Zou J; Wang T; He M; Bolon YT; Gadalla SM; Marsh SGE; Kuxhausen M; Gale RP; Sharma A; Assal A; Prestidge T; Aljurf M; Cerny J; Paczesny S; Spellman SR; Lee SJ; Ciurea SO
Transplant Cell Ther; 2022 Feb; 28(2):107.e1-107.e8. PubMed ID: 34774819
[TBL] [Abstract][Full Text] [Related]
3. Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation.
Zou J; Kongtim P; Oran B; Srour SA; Greenbaum U; Carmazzi Y; Rondon G; Ciurea SO; Ma Q; Shpall EJ; Champlin RE; Cao K
Cancer; 2023 Apr; 129(8):1205-1216. PubMed ID: 36738229
[TBL] [Abstract][Full Text] [Related]
4. Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.
Zou J; Kongtim P; Oran B; Kosmoliaptsis V; Carmazzi Y; Ma J; Li L; Rondon G; Srour S; Copley HC; Partlow D; Ciurea SO; Greenbaum U; Ma Q; Shpall EJ; Champlin RE; Cao K
Haematologica; 2022 Apr; 107(4):844-856. PubMed ID: 34435482
[TBL] [Abstract][Full Text] [Related]
5. HLA epitope mismatch in haploidentical transplantation is associated with decreased relapse and delayed engraftment.
Rimando J; Slade M; DiPersio JF; Westervelt P; Gao F; Liu C; Romee R
Blood Adv; 2018 Dec; 2(24):3590-3601. PubMed ID: 30563883
[TBL] [Abstract][Full Text] [Related]
6. The Predicted Indirectly Recognizable HLA Epitopes (PIRCHE) Score for HLA Class I Graft-versus-Host Disparity Is Associated with Increased Acute Graft-versus-Host Disease in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.
Rimando J; Slade M; DiPersio JF; Westervelt P; Gao F; Liu C; Romee R
Biol Blood Marrow Transplant; 2020 Jan; 26(1):123-131. PubMed ID: 31563575
[TBL] [Abstract][Full Text] [Related]
7. Various approaches for accessing the influence of human leukocyte antigens disparity in haploidentical stem cell transplantation.
Grubic Z; Burek Kamenaric M; Maskalan M; Durakovic N; Vrhovac R; Stingl Jankovic K; Serventi Seiwerth R; Zunec R
Int J Lab Hematol; 2022 Jun; 44(3):547-557. PubMed ID: 35253380
[TBL] [Abstract][Full Text] [Related]
8. IMPACT OF HLA-DPB1 MATCHING ON CLINICAL OUTCOMES AFTER HAPLOIDENTICAL-RELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION.
Jaime-Pérez JC; Cancela-Murrieta CO; Salazar-Cavazos L; Aguilar-Calderón PE; Salazar-Riojas R; Méndez-Ramírez N; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Gómez-Almaguer D
Rev Invest Clin; 2020; 72(2):69-79. PubMed ID: 32284622
[TBL] [Abstract][Full Text] [Related]
9. [Impact of mismatched HLA on graft-versus-host disease in unrelated stem cell transplantation].
Morishima S
Rinsho Ketsueki; 2018; 59(8):1086-1094. PubMed ID: 30185710
[TBL] [Abstract][Full Text] [Related]
10. Alternative donor strategy in unrelated hematopoietic stem cell transplantation - outcome with mismatched donors.
Grubic Z; Maskalan M; Burek Kamenaric M; Desnica L; Mikulic M; Stingl Jankovic K; Durakovic N; Serventi Seiwerth R; Vrhovac R; Zunec R
Adv Med Sci; 2023 Sep; 68(2):332-340. PubMed ID: 37741003
[TBL] [Abstract][Full Text] [Related]
11. Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide.
Raiola AM; Risitano A; Sacchi N; Giannoni L; Signori A; Aquino S; Bregante S; Di Grazia C; Dominietto A; Geroldi S; Ghiso A; Gualandi F; Lamparelli T; Tedone E; Van Lint MT; Varaldo R; Ibatici A; Marani C; Marotta S; Guolo F; Avenoso D; Garbarino L; Pane F; Bacigalupo A; Angelucci E
Biol Blood Marrow Transplant; 2018 Jan; 24(1):119-126. PubMed ID: 29024804
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effect of major histocompatibility complex class I-related chain a and human leukocyte antigen-DPB1 mismatches in association with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation.
Askar M; Sun Y; Rybicki L; Zhang A; Thomas D; Kalaycio M; Pohlman B; Dean R; Duong H; Hanna R; Maciejewski J; Majhail NS; Bolwell B; Sobecks R
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1835-40. PubMed ID: 25064744
[TBL] [Abstract][Full Text] [Related]
13. The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent.
Agarwal RK; Kumari A; Sedai A; Parmar L; Dhanya R; Faulkner L
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1592-1596. PubMed ID: 28603069
[TBL] [Abstract][Full Text] [Related]
14. Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables.
Solomon SR; Aubrey MT; Zhang X; Piluso A; Freed BM; Brown S; Jackson KC; Morris LE; Holland HK; Solh MM; Bashey A
Biol Blood Marrow Transplant; 2018 Apr; 24(4):789-798. PubMed ID: 29355721
[TBL] [Abstract][Full Text] [Related]
15. The impact of HLA matching on outcomes of unmanipulated haploidentical HSCT is modulated by GVHD prophylaxis.
Lorentino F; Labopin M; Fleischhauer K; Ciceri F; Mueller CR; Ruggeri A; Shimoni A; Bornhäuser M; Bacigalupo A; Gülbas Z; Koc Y; Arcese W; Bruno B; Tischer J; Blaise D; Messina G; Beelen DW; Nagler A; Mohty M
Blood Adv; 2017 Apr; 1(11):669-680. PubMed ID: 29296709
[TBL] [Abstract][Full Text] [Related]
16. Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.
Konuma T; Kanda J; Yamasaki S; Harada K; Shimomura Y; Terakura S; Mizuno S; Uchida N; Tanaka M; Doki N; Ozawa Y; Nakamae H; Sawa M; Matsuoka KI; Morishige S; Maruyama Y; Ikegame K; Kimura T; Kanda Y; Ichinohe T; Atsuta Y; Yanada M
Transplant Cell Ther; 2021 Apr; 27(4):334.e1-334.e11. PubMed ID: 33836881
[TBL] [Abstract][Full Text] [Related]
17. Cord Haploidentical Non-In Vitro T Cell Depletion Allogeneic Hematopoietic Stem Cell Transplantation Reduces Relapse of Refractory Acute Leukemia.
Wang J; Wang Z; Wei W; Zhang W; Zhang T; Cheng H; Fei X; Yin Y; Gu J; Yuan L
Biol Blood Marrow Transplant; 2019 Jan; 25(1):121-128. PubMed ID: 30205230
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
[TBL] [Abstract][Full Text] [Related]
19. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
[TBL] [Abstract][Full Text] [Related]
20. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
